Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture provides the nine essential and non‑essential amino acids required for protein synthesis. When infused intravenously, the amino acids bypass the gastrointestinal tract, become directly available to cells, supporting tissue repair, immune function, and maintaining a neutral nitrogen balance in the body.

The dosage of Kabiven is individualized by the prescribing clinician based on the patient’s weight, metabolic needs, renal and hepatic function, and the overall nutrition plan. The healthcare professional determines the infusion volume and rate to achieve the desired amino acid intake.

Safety data for Kabiven in pregnancy and lactation are limited, and the product is generally reserved for situations where the benefits outweigh potential risks. Clinicians should assess the maternal and fetal condition carefully and consider alternative nutrition strategies when possible.

To place an order, submit an enquiry on the Kabiven product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including any cold‑chain requirements—and necessary import documentation.

Kabiven contains a balanced profile of ten amino acids that meets the European Pharmacopeia specifications for parenteral nutrition. Compared with some older formulations that may lack certain essential amino acids, Kabiven offers a more complete amino acid spectrum, potentially improving protein synthesis efficiency and reducing the need for supplemental individual amino acids.

Kabiven must be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. The container should remain in its original packaging until use, and any unused portion should be discarded according to local regulations after the recommended in‑use period.

Kabiven is administered intravenously as a sterile solution for injection. The infusion is typically given through a central or peripheral venous line, using a calibrated infusion pump or gravity drip, at a rate prescribed by the clinician. Compatibility with other IV fluids should be confirmed before mixing.

Serious risks include metabolic acidosis, hyperammonemia, severe allergic reactions such as anaphylaxis, renal impairment, and catheter‑related sepsis. Patients should be closely monitored for changes in blood pH, ammonia levels, kidney function, and signs of hypersensitivity throughout the infusion.

Kabiven is contraindicated in patients with known hypersensitivity to any of its amino acid components, those with severe hepatic failure where ammonia clearance is compromised, and individuals with uncontrolled electrolyte disturbances that cannot be corrected before therapy. Clinical judgment is required for patients with unstable renal function or severe metabolic disorders.